surgical patients with malignant tumor
Conditions
Interventions
None listed
Sponsors
Department of anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were scheduled to undergo hemodilutional autologous transfusion during the urological and gynecological surgery
Exclusion criteria
Exclusion criteria: Preoperative hemoglobin < 11 g/dl A past history of ischemic heart disease and/or central nervous systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy of noninvasive hemoglobin measurement | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of several variables on the accuracy of noninvasive hemoglobin measurement | — |
Countries
Japan
Outcome results
None listed